Raffi Asadorian, Chief Financial Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 5,000 shares at $3.13 ($16K) on 2018-11-13, disclosed to the SEC on 2018-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ACRX | BUY | 2019-03-04 | $10K | — | Filing → |
| ACRX | BUY | 2018-12-17 | $14K | — | Filing → |
| ACRX | BUY | 2018-08-06 | $14K | — | Filing → |